Yeni Şafak English

Moderna's COVID-19 vaccine candidate moves into late-stage trial

News Service
11:4227/07/2020, Monday
U: 27/07/2020, Monday
REUTERS
File photo
File photo

Moderna Inc said on Monday it has started a U.S. government-backed late-stage trial evaluating its COVID-19 vaccine candidate, mRNA-1273, in about 30,000 adults who do not have the respiratory illness caused by the new coronavirus.

The main goal of the study will be prevention of the symptomatic COVID-19 disease, the company said.

#Moderna
#vaccine
Comments

Hello, the comments you share on our site are a valuable resource for other users. Please respect other users and different opinions. Do not use rude, offensive, derogatory, or discriminatory language.

No comments yet

The floor is all yours.

Click here to receive the most important news of the day by email. Subscribe here.

By subscribing, you agree to receive electronic communications from Albayrak Media Group websites and accept the Terms of Use and Privacy Policy.